D.E. Shaw & Co
APLT

D.E. Shaw & Co’s Applied Therapeutics APLT Stock Holding History

D.E. Shaw & Co’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-17,799
Closed -$15.2K – 4234
2024
Q4 		$15.2K Sell
17,799
-19,436
-52% -$122K ﹤0.01% 4254
2024
Q3 		$316K Buy
+37,235
New +$219K ﹤0.01% 3950
2022
Q3 		– Sell
-71,098
Closed -$67K – 5159
2022
Q2 		$67K Sell
71,098
-75,325
-51% -$123K ﹤0.01% 4798
2022
Q1 		$309K Buy
+146,423
New +$392K ﹤0.01% 4635
2020
Q2 		– Sell
-36,338
Closed -$1.19M – 3968
2020
Q1 		$1.19M Buy
+36,338
New +$1.47M ﹤0.01% 2604

Other funds holding APLT

VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

D.E. Shaw & Co's APLT Position: Q1 2025 in Review

D.E. Shaw & Co sold out of Applied Therapeutics (APLT) in Q1 2025, closing a stake of 17,799 shares — an estimated $15.2K sold.

D.E. Shaw & Co first reported a position in APLT in Q1 2020 and held it in 5 quarters. The position peaked at $1.19M in Q1 2020. 90 funds tracked by Wall St. Rank hold APLT as of Q1 2025.

  • D.E. Shaw & Co reported no remaining Applied Therapeutics position as of Q1 2025 after selling out during the quarter.
  • D.E. Shaw & Co sold 17,799 Applied Therapeutics shares in Q1 2025, an estimated $15.2K.
  • D.E. Shaw & Co first reported a position in Applied Therapeutics in Q1 2020 and held it in 5 quarters.
  • D.E. Shaw & Co's Applied Therapeutics position peaked at $1.19M in Q1 2020.
  • 90 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2025.

Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.